Nifty pharma slumps nearly 2 pc after Trump announces tariff plan on generic drug imports
Mumbai, July 22 (IANS) India’s pharmaceutical sector dipped notably on Wednesday after US President Donald Trump outlined a phased tariff plan on imported generic medicines, fuelling concerns over the long‑term outlook for drugmakers that rely heavily on US sales.